Astellas Audentes Therapeutics Biotech News

Astellas Pharma Completes Acquisition of Audentes Therapeutics

Biotech News | 15.01.2020

Astellas Pharma today announced that it has successfully completed the planned acquisition of...

Audentes Therapeutics Biotech News

Astellas Pharma to Buy Audentes for $3 Billion: +270 since January 2019%!

Biotech News | 02.12.2019

We have to say goodbye to our Biotech Investments Model Portfolio member Audentes Therapeutics. The...

Audentes Therapeutics Biotech News

Audentes Therapeutics Publishes Business and Pipeline Update for Second Quarter 2019

Biotech News | 06.08.2019

Audentes Therapeutics, a member of our Model Portfolio specializing in the development of gene...